ended5월 13일· 1 sources
일동제약, 1분기 영업익 92억…전년比 120% 증가
Why it matters
Illdong Pharmaceutical's explosive Q1 earnings—with operating profit doubling and net income surging 1,376%—signal strong market recovery and operational excellence in the pharmaceutical sector. This exceptional performance reflects heightened demand and positions the company for sustained competitive advantage.
1
Sources
+0
24h
—
Growth
131d
Active
PharmaceuticalEarnings surgeOperating profitNet incomeQuarterly results